Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Thuja Occidentalis
Brand Name
Bm Thuja Occ
Generic Name
Thuja Occidentalis
Active Ingredient
Thuja Occidentalis Leafy TwigCategory
Non-Standardized Food Allergenic Extract [EPC]
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 100000 [hp_C]/mL | LIQUID | ORAL | 85816-5125 |
Detailed information about Bm Thuja Occ
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Bm Thuja Occ, you must consult a qualified healthcare professional.
Thuja Occidentalis Leafy Twig is a botanical substance primarily utilized as a non-standardized allergenic extract for diagnostic testing and immunotherapy. It belongs to the class of Non-Standardized Plant Allergenic Extracts [EPC] and is often used in environmental allergy management.
Dosage is highly individualized and must be determined by an allergist.
Safety and efficacy in children have not been fully established for all forms. When used for allergy immunotherapy, pediatric dosing is generally based on the same titration schedule as adults but requires extreme caution and monitoring by a pediatric allergist.
No specific dose adjustments are provided in the labeling, but caution is advised in patients with severe renal disease due to potential changes in the clearance of botanical metabolites.
Use with caution. The liver is the primary site for metabolizing thujone and other constituents.
Older adults may be more sensitive to the adrenergic effects of the extract. Lower starting doses may be considered.
If a maintenance immunotherapy dose is missed, contact your allergist. Do not double the next dose. If a significant amount of time has passed, the dose may need to be reduced to ensure safety.
Signs of overdose (especially with oral ingestion or excessive injection) include seizures, severe vomiting, hypotension (low blood pressure), and tachycardia (rapid heartbeat). In case of accidental ingestion, contact a poison control center immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
> Warning: Stop taking Thuja Occidentalis Leafy Twig and call your doctor immediately if you experience any of these.
Prolonged use in immunotherapy is generally well-tolerated; however, some patients may develop persistent local nodules at the injection site. Long-term oral use of non-homeopathic Thuja is discouraged due to the potential for cumulative thujone toxicity.
Many allergenic extracts carry a Boxed Warning regarding the risk of severe non-fatal and fatal systemic allergic reactions (anaphylaxis). These extracts should only be administered by physicians prepared to treat such reactions and in facilities equipped with emergency equipment (e.g., epinephrine).
Thuja Occidentalis Leafy Twig must be used with extreme caution in patients with unstable asthma, as they are at a higher risk for severe reactions during immunotherapy.
WARNING: RISK OF ANAPHYLAXIS. This product can cause severe systemic allergic reactions, including anaphylaxis, which may be fatal. Patients must be observed for at least 30 minutes after administration. This product should only be administered by healthcare providers trained in the management of life-threatening allergic reactions.
Patients should avoid driving or operating heavy machinery for at least 30 minutes after an injection, as dizziness or systemic reactions can occur suddenly.
Alcohol may increase the rate of absorption of certain botanical constituents and could potentially worsen an allergic reaction. It is best to avoid alcohol on the day of immunotherapy.
If a patient experiences a systemic reaction, the immunotherapy program must be re-evaluated. Tapering is not typically required for allergenic extracts, but the decision to stop should be made by an allergist.
> Important: Discuss all your medical conditions with your healthcare provider before starting Thuja Occidentalis Leafy Twig.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Patients allergic to other members of the Cupressaceae family (such as Juniper or Cypress) may exhibit cross-reactivity to Thuja Occidentalis Leafy Twig.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Thuja Occidentalis Leafy Twig.
Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. It is generally recommended that immunotherapy doses not be increased during pregnancy, although maintenance doses may sometimes be continued if the benefit outweighs the risk of anaphylaxis to the fetus.
It is unknown if the components of Thuja extract are excreted in human milk. Caution should be exercised when administered to a nursing woman. The risk of a systemic reaction in the mother, which could affect the infant, must be considered.
While used in children for allergy management, the risk-benefit ratio must be carefully assessed. Children may have difficulty communicating the early symptoms of a systemic reaction. It is generally not recommended for children under the age of 5.
Elderly patients may have a higher prevalence of cardiovascular disease, making them more vulnerable to the effects of epinephrine if it is needed to treat an allergic reaction. Renal and hepatic function should be assessed before starting therapy.
No specific GFR-based adjustments are established; however, since metabolites are renally excreted, patients with Stage 4 or 5 Chronic Kidney Disease should be monitored for signs of cumulative toxicity.
In patients with Child-Pugh Class B or C impairment, the metabolism of thujone may be significantly delayed, increasing the risk of neurotoxic side effects.
> Important: Special populations require individualized medical assessment.
Thuja Occidentalis Leafy Twig acts as a complex biological modifier. In the context of Allergenic Extracts, it introduces specific antigens to the immune system. This leads to the production of IgG4 'blocking' antibodies, which compete with IgE for allergen binding, thereby preventing mast cell degranulation.
Additionally, its role as an Androgen Receptor Agonist and Adrenergic Agonist involves binding to nuclear receptors and G-protein coupled receptors (GPCRs), respectively. These pathways are thought to modulate cellular metabolism and sympathetic tone, though their clinical significance in standard allergy treatment is secondary to the immunologic effects.
| Parameter | Value |
|---|---|
| Bioavailability | Low (Subcutaneous); Variable (Oral) |
| Protein Binding | Unknown |
| Half-life | 24–48 hours (Constituents like Thujone) |
| Tmax | 1–3 hours (Systemic absorption post-injection) |
| Metabolism | Hepatic (CYP-mediated) |
| Excretion | Renal (>70%), Fecal (<20%) |
Thuja Occidentalis Leafy Twig is a Non-Standardized Plant Allergenic Extract. It shares therapeutic space with other coniferous extracts like Cedar and Pine extracts.
Common questions about Bm Thuja Occ
Thuja Occidentalis Leafy Twig is primarily used in clinical medicine as an allergenic extract for the diagnosis and treatment of allergies. Healthcare providers use it in skin prick tests to determine if a patient is allergic to the Eastern White Cedar plant. If an allergy is confirmed, it may be used in 'allergy shots' (immunotherapy) to help the body build a tolerance to the allergen over time. Beyond allergy, it is also found in various traditional and homeopathic preparations for skin conditions like warts, though these uses are not standard prescription indications. Always consult an allergist for proper use in a clinical setting.
The most common side effects associated with Thuja Occidentalis Leafy Twig, especially when given as an injection, are local reactions at the site of administration. These include redness, itching, and swelling, which usually appear shortly after the injection and resolve within a day. Some patients may also experience a temporary increase in their typical allergy symptoms, such as sneezing or a runny nose. Systemic symptoms like fatigue or a mild headache are also frequently reported. While these are common, any reaction that spreads beyond the injection site should be reported to a doctor immediately.
It is generally advised to avoid alcohol consumption on the days you receive Thuja Occidentalis Leafy Twig injections. Alcohol can dilate blood vessels and potentially increase the speed at which the allergen enters your bloodstream, which may raise the risk of a systemic allergic reaction. Furthermore, alcohol can mask the early symptoms of anaphylaxis, making it harder for you or your doctor to recognize an emergency. If you are using homeopathic oral forms, alcohol may still interfere with the body's response to the treatment. Discuss your alcohol consumption habits with your healthcare provider before starting therapy.
The safety of Thuja Occidentalis Leafy Twig during pregnancy has not been established through rigorous clinical trials, placing it in FDA Pregnancy Category C. Most allergists recommend against starting new immunotherapy during pregnancy due to the risk of a severe allergic reaction (anaphylaxis), which could deprive the fetus of oxygen. However, if a woman is already on a stable maintenance dose and is tolerating it well, the doctor may choose to continue the treatment without increasing the dose. Oral forms containing thujone should be strictly avoided as they may have uterine-stimulating effects. Always inform your doctor if you are pregnant or planning to become pregnant.
The timeframe for Thuja Occidentalis Leafy Twig to show results depends on how it is being used. For diagnostic skin testing, results are visible within 15 to 20 minutes of application. For allergenic immunotherapy, the process is much slower; patients typically undergo a 'build-up phase' lasting several months before reaching a maintenance dose. Most patients begin to notice a reduction in their allergy symptoms after 3 to 6 months of consistent treatment. Full clinical benefit is often achieved after one year of therapy, and treatment usually continues for 3 to 5 years for long-lasting immunity.
Stopping Thuja Occidentalis Leafy Twig immunotherapy suddenly does not typically cause a withdrawal syndrome like some other medications. However, if you stop the treatment before the recommended 3-to-5-year course is complete, your allergy symptoms are likely to return over time. If you miss several doses, you cannot simply restart at the same level, as your sensitivity may have increased; your doctor will need to adjust the dose downward for safety. If you are using it for other purposes, sudden discontinuation is generally safe but should be discussed with your provider. Always coordinate any changes in your treatment plan with your medical team.
If you miss a scheduled injection of Thuja Occidentalis Leafy Twig, contact your allergist's office as soon as possible to reschedule. The procedure for a missed dose depends on how long it has been since your last injection. If only a few days have passed, you may be able to continue with your scheduled dose. However, if several weeks have passed, your doctor may need to reduce the dose to prevent a severe allergic reaction when you restart. Never attempt to double the dose or administer it yourself at home to 'catch up.'
There is currently no clinical evidence to suggest that Thuja Occidentalis Leafy Twig causes weight gain. Unlike certain medications like corticosteroids or some antidepressants, allergenic extracts do not typically interfere with metabolic rate or appetite. If you notice significant weight changes while undergoing immunotherapy, it is likely due to other factors or medications. It is important to discuss any unexpected physical changes with your healthcare provider to identify the underlying cause. Maintaining a healthy lifestyle and monitoring for other side effects is always recommended during long-term treatment.
Thuja Occidentalis Leafy Twig can interact with several types of medications, some of which are very important. For example, taking beta-blockers (often used for blood pressure) can make it dangerous to receive this extract because they interfere with the effectiveness of epinephrine in an emergency. Antihistamines can interfere with the results of skin tests, so they must be stopped a few days prior to testing. Other medications that affect the immune system or the heart should be reviewed by your doctor. Always provide a complete list of your current medications, including over-the-counter drugs and herbal supplements, to your allergist.
Thuja Occidentalis Leafy Twig is a botanical extract and is not marketed as a 'generic' in the same way that synthetic drugs like ibuprofen are. Instead, it is produced by various specialized laboratories as a non-standardized allergenic extract. While different manufacturers may produce the extract, they are not necessarily interchangeable because the concentration of active proteins can vary between batches. In the world of homeopathy, many different brands offer Thuja products, but these are not regulated for bioequivalence like generic pharmaceuticals. Always use the specific brand or preparation recommended by your specialist.
Other drugs with the same active ingredient (Thuja Occidentalis Leafy Twig)